{"DataElement":{"publicId":"7680851","version":"1","preferredName":"Leukodystrophy Diagnosis Evaluation Method Type","preferredDefinition":"A description of the evaluation method used to diagnose leukodystrophy.","longName":"7680834v1.0:2974012v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"7680834","version":"1","preferredName":"Leukodystrophy Diagnosis Evaluation Method","preferredDefinition":"A group of rare genetic neurodegenerative disorders that affect infants and children. These disorders are characterized by metabolic abnormalities in the development of the myelin sheaths in the white matter. Clinical signs and symptoms include developmental delays, mental retardation, dementia, seizures, loss of motor skills, and muscle weakness. Representative examples include metachromatic leukodystrophy, Krabbe disease, Canavan disease, and Alexander disease._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"7680832v1.0:2974008v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"7680832","version":"1","preferredName":"Leukodystrophy Diagnosis","preferredDefinition":"A group of rare genetic neurodegenerative disorders that affect infants and children. These disorders are characterized by metabolic abnormalities in the development of the myelin sheaths in the white matter. Clinical signs and symptoms include developmental delays, mental retardation, dementia, seizures, loss of motor skills, and muscle weakness. Representative examples include metachromatic leukodystrophy, Krabbe disease, Canavan disease, and Alexander disease.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C61253:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukodystrophy","conceptCode":"C61253","definition":"A group of rare genetic neurodegenerative disorders that affect infants and children. These disorders are characterized by metabolic abnormalities in the development of the myelin sheaths in the white matter. Clinical signs and symptoms include developmental delays, mental retardation, dementia, seizures, loss of motor skills, and muscle weakness. Representative examples include metachromatic leukodystrophy, Krabbe disease, Canavan disease, and Alexander disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4425661-FDFF-06CD-E053-4EBD850A8EFF","latestVersionIndicator":"Yes","beginDate":"2021-06-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-06-08","modifiedBy":"ONEDATA","dateModified":"2021-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2974008","version":"1","preferredName":"Evaluation Method","preferredDefinition":"Evaluation; the act of placing value on something.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"C25214:C71460","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-103B-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"ONEDATA","dateModified":"2009-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4425661-FE0D-06CD-E053-4EBD850A8EFF","latestVersionIndicator":"Yes","beginDate":"2021-06-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-06-08","modifiedBy":"MALUMK","dateModified":"2021-11-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2974012","version":"1","preferredName":"Evaluation Method Type","preferredDefinition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Type; a subdivision of a particular kind of thing.","longName":"E_M_T","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Immunofluorescence","valueDescription":"Immunologic Technique Fluorescence","ValueMeaning":{"publicId":"2974013","version":"1","preferredName":"Immunologic Technique Fluorescence","longName":"2974013","preferredDefinition":"Laboratory technique involving interaction of antigens with specific antibodies.: Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunology Test","conceptCode":"C16723","definition":"Laboratory test involving interaction of antigens with specific antibodies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence","conceptCode":"C16586","definition":"Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-108A-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BCD2B56-10A3-3667-E040-BB89AD436539","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"ONEDATA","dateModified":"2009-12-28","deletedIndicator":"No"},{"value":"Flow cytometric analysis","valueDescription":"Flow Cytometry","ValueMeaning":{"publicId":"2974014","version":"1","preferredName":"Flow Cytometry","longName":"2974014","preferredDefinition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Flow Cytometry","conceptCode":"C16585","definition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-10AD-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BCD2B56-10C6-3667-E040-BB89AD436539","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"ONEDATA","dateModified":"2009-12-28","deletedIndicator":"No"},{"value":"Bone marrow morphology","valueDescription":"Bone Marrow Morphology","ValueMeaning":{"publicId":"2974015","version":"1","preferredName":"Bone Marrow Morphology","longName":"2974015","preferredDefinition":"The soft, sponge-like tissue in the center of bones that produces white blood cells, red blood cells, and platelets.: Morphology is the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Marrow","conceptCode":"C12431","definition":"The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Morphology","conceptCode":"C17943","definition":"The science of the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same.  In pathology, the specific appearance of cells and tissues (normal and abnormal) under the light or electron microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-10D3-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BCD2B56-10EC-3667-E040-BB89AD436539","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"ONEDATA","dateModified":"2009-12-28","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"498B0E12-9B53-79DC-E053-F662850A0B75","beginDate":"2017-02-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-27","modifiedBy":"ONEDATA","dateModified":"2017-02-27","deletedIndicator":"No"},{"value":"Quantitative PCR","valueDescription":"Quantitative Result Polymerase Chain Reaction","ValueMeaning":{"publicId":"5682948","version":"1","preferredName":"Quantitative Result Polymerase Chain Reaction","longName":"5682948","preferredDefinition":"An outcome or conclusion that can be arrived at by measurement.: A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quantitative Result","conceptCode":"C49148","definition":"An outcome or conclusion that can be arrived at by measurement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9B60-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"498B0E12-9B79-79DC-E053-F662850A0B75","beginDate":"2017-02-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-27","modifiedBy":"ONEDATA","dateModified":"2017-02-27","deletedIndicator":"No"},{"value":"MS-PCR","valueDescription":"Methylation Polymerase Chain Reaction","ValueMeaning":{"publicId":"5682949","version":"1","preferredName":"Methylation Polymerase Chain Reaction","longName":"5682949","preferredDefinition":"The covalent chemical or biochemical addition of a methyl group(s) to a compound. (NCI): A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Methylation","conceptCode":"C16848","definition":"The covalent chemical or biochemical addition of a methyl group(s) to a compound. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9B86-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"498B0E12-9B9F-79DC-E053-F662850A0B75","beginDate":"2017-02-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-27","modifiedBy":"ONEDATA","dateModified":"2017-02-27","deletedIndicator":"No"},{"value":"Genetic mutational panel","valueDescription":"Disease Panel Gene Sequencing","ValueMeaning":{"publicId":"7681466","version":"1","preferredName":"Disease Panel Gene Sequencing","longName":"7681466","preferredDefinition":"An application of next-generation targeted sequencing where a disease-specific group of genes or loci are assayed for sequence alterations as a screening procedure for the disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Panel Gene Sequencing","conceptCode":"C173599","definition":"An application of next-generation targeted sequencing where a disease-specific group of genes or loci are assayed for sequence alterations as a screening procedure for the disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4494FC5-502D-2D9D-E053-4EBD850AB399","latestVersionIndicator":"Yes","beginDate":"2021-06-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-06-08","modifiedBy":"ONEDATA","dateModified":"2021-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C4494FC5-5046-2D9D-E053-4EBD850AB399","beginDate":"2021-06-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-06-08","modifiedBy":"ONEDATA","dateModified":"2021-06-08","deletedIndicator":"No"},{"value":"Laboratory findings","valueDescription":"Laboratory Test Result","ValueMeaning":{"publicId":"2965078","version":"1","preferredName":"Laboratory Test Result","longName":"2965078","preferredDefinition":"The outcome of a laboratory test.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Test Result","conceptCode":"C36292","definition":"The outcome of a laboratory test.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A25BBD1-B4F1-7451-E040-BB89AD43120E","latestVersionIndicator":"Yes","beginDate":"2009-12-07","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-07","modifiedBy":"KUMMEROA","dateModified":"2023-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C4439226-9043-4BE3-E053-4EBD850ABBED","beginDate":"2021-06-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-06-08","modifiedBy":"ONEDATA","dateModified":"2021-06-08","deletedIndicator":"No"},{"value":"Newborn screening","valueDescription":"Newborn Screening","ValueMeaning":{"publicId":"7680792","version":"1","preferredName":"Newborn Screening","longName":"7680792","preferredDefinition":"A specific type of newborn examination performed to allow for early detection of disease(s) and/or disorder(s).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Newborn Screening","conceptCode":"C81178","definition":"A specific type of newborn examination performed to allow for early detection of disease(s) and/or disorder(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4439226-9050-4BE3-E053-4EBD850ABBED","latestVersionIndicator":"Yes","beginDate":"2021-06-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-06-08","modifiedBy":"ONEDATA","dateModified":"2021-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C4439226-9069-4BE3-E053-4EBD850ABBED","beginDate":"2021-06-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-06-08","modifiedBy":"ONEDATA","dateModified":"2021-06-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2974011","version":"1","preferredName":"Evaluation Method Type","preferredDefinition":"Evaluation; the act of placing value on something.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.:Type; a subdivision of a particular kind of thing.","longName":"C25214:C71460:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-1062-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"ONEDATA","dateModified":"2009-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-1073-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"MALUMK","dateModified":"2021-06-08","changeDescription":"Added 3 PVs for MC. AK 2/27/17. PVs added for 2037r3. 06/08/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the evaluation metho","type":"Preferred Question Text","description":"What was the evaluation method used to diagnose leukodystrophy?","url":null,"context":"NHLBI"},{"name":"Specify testing performed to establish the diagnosis","type":"Application Standard Question Text","description":"Specify testing performed to establish the diagnosis","url":null,"context":"NHLBI"},{"name":"Specify testing performed to establish the diagnosis","type":"Alternate Question Text","description":"Specify testing performed to establish the diagnosis","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C443DE1C-DDE8-61C0-E053-4EBD850A2DEA","latestVersionIndicator":"Yes","beginDate":"2021-06-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-06-08","modifiedBy":"MALUMK","dateModified":"2021-11-01","changeDescription":"Released. 11/01/2021 KMM; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}